Ciprofloxacin Hydrochloride, Ciprofloxacin — Drug Intelligence | 11 EU Trials

Filter these 11 trials by condition, phase, country and more.

Open in Search →

11 Registered trials

5 Recruiting

0 Completed trials

11 Sponsors

13 Countries

Phase III

Phase IV

Phase III: 5 Phase II: 1 Phase I/II: 1 Phase III/IV: 1 Phase IV: 3

Indications tested

Allogenic stem cell transplantation 1 Pouchitis 1 Febrile neutropenia 1 Autologous haematopoietic stem cell transplant 1 Antibiotic level therapeutic 1 Prostate cancer 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 2 Amsterdam UMC Stichting 1 Bellvitge University Hospital 1 Centre Hospitalier Regional De Marseille 1 Centre Hospitalier Universitaire De Nantes 1 Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL 1 Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias 1 Instituto De Investigacion Marques De Valdecilla 1 SpectraCure AB (publ) 1 Takeda Development Center Americas Inc. 1 Uppsala Universitet 1

All trials

11 total

AIR. ANTIBIOTIC THERAPY IN RESPIRATORY TRACT INFECTIONS A controlled randomized, open label, multicenter, non-inferiority trial evaluating a… Pending

2024-516097-30-00 Phase IV 1 country Assistance Publique Hopitaux De Paris
Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
Open-label clinical phase 1/2 study to assess the safety and efficacy of the SpectraCure P18 System and verteporfin for injection for the tr… Pending

2024-519658-35-00 Phase I/II 1 country SpectraCure AB (publ)
A multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients: efficacy and microbiologi… Pending

2024-520336-14-00 Phase III 1 country Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De A…
Efficacy of an empirical treatment with Amoxicillin-clavulanate (AC) compared to the combination Amoxicillin-clavulanate and Ciprofloxacin (… Pending

2025-520995-24-00 Phase III 1 country Centre Hospitalier De Versailles
STUDY TO FIND OUT WHETHER A SHORTER ANTIBIOTIC TREATMENT (7 DAYS) IS AS EFFECTIVE AND SAFE AS THE USUAL ONE (14 DAYS) IN PATIENTS WITH AN IN… Pending

2025-523120-53-00 Phase III/IV 1 country Bellvitge University Hospital; Fundacio Institut D'Investigacio Biomedica De Bel…
Evaluation of the efficacy of treatment with autovaccines vs antibiotic treatment in subjects with hip or knee prosthesis infections. Recruiting

2024-520226-10-00 Phase III 1 country Instituto De Investigacion Marques De Valdecilla
Efficacy and Safety of Vedolizumab Intravenous in Pediatric Chronic Pouchitis Recruiting

2023-504773-20-00 Phase III 8 countries Takeda Development Center Americas Inc.
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting

2023-503447-33-00 Phase II 2 countries Uppsala Universitet
Revised dosing of Ciprofloxacin for patients with impaired renal function: a bioequivalence study Recruiting

2024-520379-28-00 Phase IV 1 country Amsterdam UMC Stichting
Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre… Recruiting

2024-514952-34-00 Phase III 1 country Assistance Publique Hopitaux De Paris

Showing 1–11 of 11 trials

← All drugs A–Z